Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone-metformin plus dapagliflozin versus basal insulin plus metformin in inadequately controlled type 2 diabetes
ChiCTR2000036076Phase 4Not yet recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pioglitazone, metformin and dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Shanghai General Hospital. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
pioglitazonemetformindapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000036076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036076.